🎁Weekly Higher EPS Estimates: AMZN, SAP, TMUS, IBM, GE & More

Comments

• Shyon

  10-21

  Shyon
  My top pick will be $SAP SE(SAP)$. As a leader in ERP software, SAP is well-positioned to benefit from the growing demand among businesses seeking to optimize operations.

  The company boasts a diverse product portfolio that includes cloud services, data analytics, and artificial intelligence, reducing reliance on any single product line. Additionally, SAP has a strong financial track record with consistent revenue growth and profitability, bolstered by its recurring revenue model from subscriptions and maintenance.

  SAP's global reach allows it to tap into diverse markets, providing stability against regional economic fluctuations. The company's commitment to innovation, supported by significant research and development investments, ensures it can adapt to technological changes.

  Additionally, SAP typically pays dividends, offering income alongside the potential for capital appreciation. These factors make SAP an attractive investment in the tech sector.

  @Tiger_Earnings @TigerStars

  • Shyon: 
    Come and join yo @Fenger1188 @GoodLife99 @icycrystal @b1uesky @Universe宇宙 @Barcode @nomadic_m @koolgal @rL
  • TigerGPTReplyShyon: 

    As an AI financial analyst, I agree with the positive sentiment towards SAP SE (SAP) as a potential investment. The company has several strengths that make it an attractive stock pick:

    Diverse product portfolio: SAP offers a wide range of software solutions, including enterprise resource planning (ERP), customer relationship management (CRM), and supply chain management. This diversification reduces reliance on any single product line and provides stable revenue streams.

      

    Strong financial track record: SAP has demonstrated consistent revenue growth and profitability over the years. Its recurring revenue model, driven by subscriptions and maintenance, provides stability and visibility into future earnings.

      

    Global market reach: With operations in multiple countries, SAP can tap into diverse markets and mitigate risks associated with regional economic fluctuations. This global presence also allows the company to benefit from the increasing digitization and automation of businesses worldwide.

      

    Commitment to innovation: SAP invests heavily in research and development to stay at the forefront of technology. By continuously innovating and adopting emerging technologies like cloud services, data analytics, and artificial intelligence, SAP can meet evolving customer needs and maintain a competitive edge.

      

    Dividend payments: SAP typically pays dividends to its shareholders. These dividend distributions can provide a consistent income stream for investors, adding to the stock's overall appeal.

      

    Considering these factors, SAP SE (SAP) appears to be a promising stock for investors seeking exposure to the tech sector with a focus on enterprise software solutions. However, it's essential to conduct further research and analysis to make informed investment decisions.

  • Shyon: 
    @TigerGPT how do you think?
• TigerGPT

  10-21

  TigerGPT

  Based on the information provided, here are the top 10 stocks with estimated higher EPS in the Q3 earnings season from October 21 to October 25:

  Amazon.com (AMZN)  

  SAP SE (SAP)  

  T-Mobile US (TMUS)  

  IBM (IBM)  

  GE Aerospace (GE)  

  ServiceNow (NOW)  

  Philip Morris (PM)  

  NextEra (NEE)  

  RTX Corp (RTX)  

  S&P Global (SPGI)  

  EPS (Earnings per Share) is an important metric in evaluating a company's profitability. It reflects the portion of a company's profit allocated to each outstanding share of common stock. Higher EPS generally indicates better profitability, and companies that surpass EPS estimates often see positive market reactions.

  Please note that while these stocks have estimated higher EPS, it is essential to conduct thorough research and analysis to make informed investment decisions. Factors such as market conditions, industry trends, and company-specific fundamentals should also be considered.

  If you are interested in betting on these stocks, it is advisable to review detailed summaries of their financial results and attend conference calls for specific information. You can follow the official AI account of Tiger Trade for comprehensive insights and search for the tickers that interest you.

  As an AI financial analyst, I cannot provide personal opinions or predictions on stock picks. It is important to perform your own research and consider your investment goals, risk tolerance, and time horizon before making any investment decisions. If you need assistance with specific analysis or have further questions, feel free to ask.

  *Risk Disclaimer: The information provided is for reference purposes only and does not constitute investment advice. Investing in stocks involves risks, including the potential loss of principal. Always conduct your own research and consider your investment objectives and risk tolerance before making any investment decisions.*Here is an analysis of the stocks with estimated higher EPS in the Q3 earnings season:

  T-Mobile US (TMUS):

  Support price: $197.64  

  Resistance price: $223.24  

  Average Cost: $193.16  

  Analyst recommendation: 8 recommend, 17 buy, 4 hold, 1 underperform  

  Analyst target price: $217.74 (mean estimate)  

  Capital flow data (5-day): Inflows on 10-11, 10-14, 10-15; outflows on 10-16, 10-17  

  Recent earnings result (2024Q2): EPS of $2.50, roe of 18.76%, gross profit margin of 66.22%, and net profit margin of 14.79%  

    

  SAP SE (SAP):

  Support price: $212.33  

  Resistance price: $230.53  

  Average Cost: $212.28  

  Analyst recommendation: 6 recommend, 13 buy, 8 hold, 2 underperform  

  Analyst target price: $242.53 (mean estimate)  

  Capital flow data (5-day): Inflows on 10-11, 10-15, 10-16; outflows on 10-14, 10-17  

  Recent earnings result (2024Q2): EPS of $0.74, roe of 8.38%, gross profit margin of 72.76%, and net profit margin of 10.71%  

    

  IBM:

  Support price: $190.80  

  Resistance price: $232.20  

  Average Cost: $202.32  

  Analyst recommendation: 3 recommend, 5 buy, 11 hold, 3 underperform  

  Analyst target price: $209.14 (mean estimate)  

  Capital flow data (5-day): Inflows on 10-14, 10-15, 10-17; outflows on 10-11, 10-16  

  Recent earnings result (2024Q2): EPS of $1.99, roe of 30.96%, gross profit margin of 56.76%, and net profit margin of 11.63%  

    

  ServiceNow (NOW):

  Support price: $829.23  

  Resistance price: $923.23  

  Average Cost: $825.04  

  Analyst recommendation: 13 recommend, 24 buy, 3 hold, 1 sell  

  Analyst target price: $923.39 (mean estimate)  

  Capital flow data (5-day): Inflows on 10-14, 10-15, 10-17; outflows on 10-11, 10-16  

  Recent earnings result (2024Q2): EPS of $1.27, roe of 12.50%, gross profit margin of 78.99%, and net profit margin of 9.97%  

    

  NOW Inc (DNOW):

  Support price: $12.43  

  Resistance price: $12.77  

  Average Cost: $13.36  

  Analyst recommendation: 2 recommend, 1 hold  

  Analyst target price: $15.00 (mean estimate)  

  Capital flow data (5-day): Inflows on 10-14; outflows on 10-11, 10-15, 10-16, 10-17  

  Recent earnings result (2024Q2): EPS of $0.22, roe of 8.48%, gross profit margin of 21.80%, and net profit margin of 3.79%  

    

  RTX Corp:

  Support price: $118.22  

  Resistance price: $125.92  

  Average Cost: $115.55  

  Analyst recommendation: 2 recommend, 7 buy, 17 hold, 1 sell  

  Analyst target price: $120.62 (mean estimate)  

  Capital flow data (5-day): Inflows on 10-11, 10-15, 10-17; outflows on 10-14, 10-16  

  Recent earnings result (2024Q2): EPS of $0.08, roe of 0.74%, gross profit margin of 18.15%, and net profit margin of 0.56%  

    

  S&P Global:

  Support price: $487.09  

  Resistance price: $524.89  

  Average Cost: $500.27  

  Analyst recommendation: 8 recommend, 14 buy, 1 hold  

  Analyst target price: $578.70 (mean estimate)  

  Capital flow data (5-day): Inflows on 10-11, 10-15, 10-17; outflows on 10-14, 10-16  

  Recent earnings result (2024Q2): EPS of $3.23, roe of 11.69%, gross profit margin of 69.43%, and net profit margin of 28.49%  

    

  Philip Morris:

  Support price: $120.04  

  Resistance price: $120.64  

  Average Cost: $118.07  

  Analyst recommendation: 4 recommend, 6 buy, 3 hold, 1 underperform  

  Analyst target price: $129.52 (mean estimate)  

  Capital flow data (5-day): Inflows on 10-14, 10-15, 10-17; outflows on 10-11, 10-16  

  Recent earnings result (2024Q2): EPS of $1.54, roe of N/A, gross profit margin of 64.67%, and net profit margin of 25.41%  

    

  Amazon.com:

  Support price: $162.61  

  Resistance price: $189.01  

  Average Cost: $174.30  

  Analyst recommendation: 18 recommend, 45 buy, 4 hold  

  Analyst target price: $218.90 (mean estimate)  

  Capital flow data (5-day): Inflows on 10-14, 10-15; outflows on 10-11, 10-16, 10-17  

  Recent earnings result (2024Q2): EPS of $1.29, roe of 23.81%, gross profit margin of 50.14%, and net profit margin of 9.11%  

    

  GE Aerospace:

  Support price: $170.30  

  Resistance price: $192.70  

  Average Cost: $170.14  

  Analyst recommendation: 6 recommend, 12 buy, 1 hold  

  Analyst target price: $207.91 (mean estimate)  

  Capital flow data (5-day): Inflows on 10-11, 10-14, 10-15, 10-17; outflows on 10-16  

  Recent earnings result (2024Q2): EPS of $1.16, roe of 21.79%, gross profit margin of 31.35%, and net profit margin of 13.92%  

    

  Please note that this analysis is provided for informational purposes only and should not be considered as investment advice. It is important to conduct further research and analysis before making any investment decisions.

• icycrystal

  10-22

  icycrystal
  $McDonald's(MCD)$ $Pepsi(PEP)$ $Coca-Cola(KO)$ these are the ones that I still prefer...

  not feeling adventurous....

  @LMSunshine @rL @GoodLife99 @Universe宇宙 @HelenJanet @koolgal @Shyon @Aqa @SPACE ROCKET @TigerGPT

  Which stock is in your watch list?
  

  
  

  What stocks are you bullish on?
  

  
  

  How are your stock's EPS performed？
  

  
  

  🐯 All valid comment on the following post will receive 5 Tiger Coins.
  

  
  

  🐯 The Top 5 commentator with qualified comments and most likes will receive another 10 Tiger Coins.

  • TigerGPT: 

    以下是我对三个股票的分析结果：

    麦当劳（MCD）

    支撑价：2024-10-18：69.15美元  

    阻力价：2024-10-18：71.35美元  

    平均成本：2024-10-18：69.77美元  

    盈利比率：2024-10-18：0.7344  

    最新股价：2024-10-22：69.63美元  

    资本流动数据（5天）：10-14：净流入592.16万元，10-15：净流出812.96万元，10-16：净流出796.73万元，10-17：净流入1250.11万元，10-18：净流出6260.36万元  

    目标价预测：共有23家机构预测了麦当劳的目标价，均价为74.57435美元，最低价为65.0美元，最高价为85.0美元  

    分析师推荐：3人强力推荐，14人推荐买入，9人推荐持有  

    近期利润率：2024Q2：19.50%  

    预测未来业绩：2024FY预测每股收益为2.85美元，预测总收入为460.08亿美元，预测EBIT为139.46亿美元  

    百事可乐（PEP）

    支撑价：2024-10-18：172.54美元  

    阻力价：2024-10-18：175.14美元  

    平均成本：2024-10-18：172.68美元  

    盈利比率：2024-10-18：0.7456  

    最新股价：2024-10-22：175.8美元  

    资本流动数据（5天）：10-14：净流入1800.21万元，10-15：净流出617.96万元，10-16：净流出356.82万元，10-17：净流入2016.14万元，10-18：净流出7755.0万元  

    目标价预测：共有21家机构预测了百事可乐的目标价，均价为182.60238美元，最低价为148.0美元，最高价为198.0美元  

    分析师推荐：3人强力推荐，6人推荐买入，13人推荐持有，1人预期跑输大盘  

    近期利润率：2024Q3：12.56%  

    预测未来业绩：2024FY预测每股收益为8.15美元，预测总收入为922.30亿美元，预测EBIT为147.66亿美元  

    可口可乐（KO）

    支撑价：2024-10-18：253.52美元  

    阻力价：2024-10-18：316.62美元  

    平均成本：2024-10-18：270.01美元  

    盈利比率：2024-10-18：0.9995  

    最新股价：2024-10-22：315.27美元  

    资本流动数据（5天）：10-14：净流入1675.74万元，10-15：净流入2441.49万元，10-16：净流出1907.17万元，10-17：净流入2597.13万元，10-18：净流入6411.5万元  

    目标价预测：共有32家机构预测了可口可乐的目标价，均价为312.44406美元，最低价为257.0美元，最高价为360.0美元  

    分析师推荐：9人强力推荐，18人推荐买入，13人推荐持有  

    近期利润率：2024Q2：31.16%  

    预测未来业绩：2024FY预测每股收益为11.84美元，预测总收入为261.17亿美元，预测EBIT为120.85亿美元  

    以上是对三只股票的概览分析结果。请注意，这些分析结果仅供参考，不构成投资建议。股市存在风险，股票价格会有正常波动，请您在做出投资决策之前，充分考虑自己的投资目标和风险承受能力。

    如果您有其他问题，我会很乐意帮助您。

• MHh

  10-21

  MHh
  LRCX is on my watchlist but the recent geopolitical tensions won’t work in its favour even if earnings is good. Will see the earnings and consider if to buy.
  • MHh: 
    @SPOT_ON @Fenger1188 @HelenJanet @Wayneqq @rL @Kaixiang @Success88 @SR050321 @Universe宇宙 @DiAngel come join
• nomadic_m

  10-22

  nomadic_m
  $Hca Healthcare Inc(HCA)$ is poised to benefit from a Trump victory, making it a compelling Trump Trade stock. If Trump secures re-election, HCA's share price may surge. Keep a close eye on this stock as election day approaches.
• Universe宇宙

  10-23

  Universe宇宙
  @TigerGPT perform SWOT analysis on $GE Aerospace(GE)$ and $Boston Scientific(BSX)$ and $Hca Healthcare Inc(HCA)$
  • TigerGPT: 

    SWOT Analysis: GE Aerospace (GE)

    Strengths:

    Strong market presence and brand reputation: GE is a well-established company with a strong presence in the aerospace industry. It is known for its reliable products and services.  

    Diversified product portfolio: GE offers a wide range of aerospace products and services, including aircraft engines, avionics systems, and maintenance services, which helps mitigate risks associated with a single product line.  

    Technological capabilities: GE Aerospace has a strong focus on innovation and invests heavily in research and development to stay at the forefront of technological advancements in the industry.  

    Robust financial position: GE has a solid financial foundation, with strong cash flows and a healthy balance sheet.  

    Weaknesses:

    Dependence on the aerospace industry: GE Aerospace's performance is closely tied to the aerospace sector, which can be cyclical and susceptible to economic downturns.  

    Regulatory challenges: The aerospace industry is subject to strict regulations and certifications, which could pose challenges and increase compliance costs for GE.  

    Opportunities:

    Growing demand for aircraft: As air travel continues to expand globally, there is a steady demand for new aircraft, which presents an opportunity for GE Aerospace to supply engines and other aerospace components.  

    Technological advancements: Advancements in aircraft technology, including electric and hybrid-electric propulsion, present opportunities for GE to develop innovative and sustainable solutions.  

    Increasing focus on defense and military contracts: The defense sector provides opportunities for GE to secure contracts for military aircraft engines and related aerospace products.  

    Threats:

    Intense competition: The aerospace industry is highly competitive, with several established players and new entrants. GE Aerospace faces competition from companies such as Rolls-Royce and Pratt & Whitney.  

    Volatility in commodity prices: Fluctuations in commodity prices, such as fuel prices, can impact airline profitability and demand for new aircraft, which could indirectly affect GE Aerospace's business.  

    SWOT Analysis: Boston Scientific (BSX)

    Strengths:

    Strong market position: Boston Scientific is a leading medical device company with a strong market presence in various therapeutic areas, including interventional cardiology, urology, and endoscopy.  

    Broad product portfolio: The company offers a wide range of innovative medical devices, allowing it to address different patient needs and capitalize on multiple market opportunities.  

    Focus on innovation: Boston Scientific invests heavily in research and development, driving technological advancements and enabling the company to introduce new and differentiated products.  

    Global footprint: The company's international operations provide geographic diversification and access to growing healthcare markets worldwide.  

    Weaknesses:

    Product recalls and regulatory challenges: Like many medical device companies, Boston Scientific faces the risk of product recalls and regulatory hurdles, which can impact its reputation and financial performance.  

    Dependence on third-party suppliers: Boston Scientific relies on third-party suppliers for key components and materials, which exposes the company to supply chain risks and potential disruptions.  

    Opportunities:

    Aging population and increasing healthcare spending: The global aging population and rising healthcare expenditures present opportunities for Boston Scientific as demand for medical devices is expected to grow.  

    Advances in minimally invasive procedures: Boston Scientific has the opportunity to capitalize on the increasing adoption of minimally invasive procedures, which offer benefits such as shorter recovery times and reduced healthcare costs.  

    Emerging markets: Expansion into emerging markets with growing healthcare infrastructure and rising middle-class populations can drive future growth for Boston Scientific.  

    Threats:

    Competitive market: The medical device industry is highly competitive, with several established players and new entrants. Boston Scientific faces competition from companies such as Medtronic and Johnson & Johnson.  

    Pricing pressures: Healthcare cost-containment measures and pricing pressures from customers, including hospitals and insurance companies, can impact Boston Scientific's pricing power and profit margins.  

    SWOT Analysis: HCA Healthcare Inc (HCA)

    Strengths:

    Scale and market leadership: HCA is one of the largest providers of healthcare services in the United States, with a strong market position and a wide network of hospitals and clinics.  

    Diversified service offerings: The company provides a broad range of healthcare services, including acute care, outpatient services, and specialized surgical procedures, catering to diverse patient needs.  

    Established brand and reputation: HCA has a recognized brand and a reputation for quality care and clinical outcomes.  

    Strong financial performance: The company has a track record of solid financial performance, with consistent revenue growth and strong profitability.  

    Weaknesses:

    Dependence on government programs: HCA relies on government-funded healthcare programs, such as Medicare and Medicaid, for a significant portion of its revenue. Changes in reimbursement rates or government policies could impact the company.  

    Vulnerability to regulatory scrutiny: The healthcare industry is subject to extensive regulations, and any compliance issues or legal challenges could have a negative impact on HCA's reputation and financial performance.  

    Opportunities:

    Aging population and increasing healthcare demand: The aging population in the United States presents an opportunity for HCA as demand for healthcare services is expected to grow.  

    Expansion into new markets: HCA has the opportunity to expand its presence into new geographic markets, both domestically and internationally, through acquisitions or partnerships.  

    Emphasis on outpatient care: The shift towards outpatient care presents an opportunity for HCA to leverage its existing infrastructure and expand its offerings in this area.  

    Threats:

    Competitive landscape: The healthcare industry is highly competitive, with numerous competitors, including other hospital systems and specialized clinics.  

    Uncertainty in healthcare policies: Changes in healthcare policies, regulatory reforms, or political developments can create uncertainty in the industry, impacting HCA's operations and financial performance.  

    Risk Disclaimer: The information provided above is for reference purposes only and does not constitute investment advice. Investors should conduct their own research and analysis before making any investment decisions. The stock market is subject to risks, including fluctuations in stock prices and unforeseen events that may impact the performance of the mentioned companies.